Design and development of photoswitchable DFG-Out RET kinase inhibitors
Open Access
- 10 March 2022
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 234, 114226
Abstract
No abstract availableKeywords
Funding Information
- Swedish Research Council
This publication has 45 references indexed in Scilit:
- A Mild Chemoselective Ru-Catalyzed Reduction of Alkynes, Ketones, and Nitro CompoundsOrganic Letters, 2013
- Small-Molecule Inducer of β Cell Proliferation Identified by High-Throughput ScreeningJournal of the American Chemical Society, 2013
- Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor GrowthMolecular Cancer Therapeutics, 2011
- Regorafenib (BAY 73‐4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activityInternational Journal of Cancer, 2010
- Highly Chemo- and Stereoselective Palladium-Catalyzed Transfer Semihydrogenation of Internal Alkynes Affording cis-AlkenesThe Journal of Organic Chemistry, 2010
- ADP-Glo: A Bioluminescent and Homogeneous ADP Monitoring Assay for KinasesASSAY and Drug Development Technologies, 2009
- Redox Potential of Azobenzene as an Amino Acid Residue in PeptidesChemBioChem, 2007
- BAY 43-9006 Inhibition of Oncogenic RET MutantsJNCI: Journal of the National Cancer Institute, 2006
- Dicarba-closo-dodecaboranes as a Pharmacophore. Retinoidal Antagonists and Potential Agonists.Chemical and Pharmaceutical Bulletin, 1999
- 4-Lithio-4'-alkylazobenzenes as Convenient Intermediates for the Preparation of Azobenzene DerivativesSynthesis, 1997